The NMCP group had a slightly older average age (55.1 years) compared to the OMCP group (53.1 years)
No, weight loss injections do not replace statin therapy in patients with established indications for lipid-lowering treatment
Testimonial and Results Disclaimer: This article references the existence of brand-reported testimonials on LIV Body's website
Prebiotic Oligosaccharides in Skin Health: Benefits, Mechanisms, and Cosmetic Applications
Liu Qiang, Chairman of YaoPharma, said: "By leveraging Pfizer's exceptional global development experience and commercialisation network, along with YaoPharma's profound expertise in small molecule R&D and manufacturing, our shared goal is to accelerate the global development and commercialisation of this innovative drug, thereby benefiting patients worldwide more rapidly and extensively." Pfizers moves with Metsera and now YaoPharma add to continued competition in the obesity drug market, which has also seen Teva Pharmaceuticals gain US Food and Drug Administration (FDA) approval in August of a generic GLP-1 of its version of Novo Nordisks injectable Saxenda (liraglutide).
The skin around our eyes is exceptionally thin and fragile
